All Access Articles |
- BridgeBio's Gene Therapy Shows Promising Results for CAH | 2024-09-11 | PHARMACEUTICAL
- BridgeBio Pharma Reports Positive Results in Phase 2 Trial of Infigratinib for Achondroplasia | 2024-06-06 | PHARMACEUTICAL
- It's Time For a Quick Look at BridgeBio Pharma's Fundamentals. | 2024-05-15 | PHARMACEUTICAL
- Key Focus Areas for BridgeBio Pharma Investors | 2024-04-11 | PHARMACEUTICAL
- Analysts' Insights on BBIO's Price Drop | 2024-01-19 | PHARMACEUTICAL
- What Do Wall Street Analysts Think of BridgeBio Pharma? | 2023-12-29 | PHARMACEUTICAL
- BridgeBio Pharma's Soaring Stock – Will the Upward Momentum Last? | 2023-12-19 | PHARMACEUTICAL
- Quick Briefing on BridgeBio Pharma | 2023-12-02 | UNITED STATES
- What Are the Fundamentals Of BBIO? | 2023-11-29 | UNITED STATES
- BBIO Investors - Our Quick Report For You. | 2023-10-30 | UNITED STATES
- What Are the Fundamentals Of BBIO? | 2023-10-11 | PHARMACEUTICAL
- Here Are the Facts You Need to Understand BBIO | 2023-08-02 | PHARMACEUTICAL
- Has Market Sentiment Shifted on BridgeBio Pharma? | 2023-07-31 | PHARMACEUTICAL